Hormone Therapy, Mental Health, and Quality of Life Among Transgender People: A Systematic Review
Abstract We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched PubMed, Embase, and PsycINFO through June 10, 2020 for studies evaluating quality of life (QOL), depression, anxiety, and death by suicide in the...
Saved in:
Published in | Journal of the Endocrine Society Vol. 5; no. 4; p. bvab011 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
US
Oxford University Press
01.04.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched PubMed, Embase, and PsycINFO through June 10, 2020 for studies evaluating quality of life (QOL), depression, anxiety, and death by suicide in the context of gender-affirming hormone therapy among transgender people of any age. We excluded case studies and studies reporting on less than 3 months of follow-up. We included 20 studies reported in 22 publications. Fifteen were trials or prospective cohorts, one was a retrospective cohort, and 4 were cross-sectional. Seven assessed QOL, 12 assessed depression, 8 assessed anxiety, and 1 assessed death by suicide. Three studies included trans-feminine people only; 7 included trans-masculine people only, and 10 included both. Three studies focused on adolescents. Hormone therapy was associated with increased QOL, decreased depression, and decreased anxiety. Associations were similar across gender identity and age. Certainty in this conclusion is limited by high risk of bias in study designs, small sample sizes, and confounding with other interventions. We could not draw any conclusions about death by suicide. Future studies should investigate the psychological benefits of hormone therapy among larger and more diverse groups of transgender people using study designs that more effectively isolate the effects of hormone treatment. |
---|---|
AbstractList | Abstract
We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched PubMed, Embase, and PsycINFO through June 10, 2020 for studies evaluating quality of life (QOL), depression, anxiety, and death by suicide in the context of gender-affirming hormone therapy among transgender people of any age. We excluded case studies and studies reporting on less than 3 months of follow-up. We included 20 studies reported in 22 publications. Fifteen were trials or prospective cohorts, one was a retrospective cohort, and 4 were cross-sectional. Seven assessed QOL, 12 assessed depression, 8 assessed anxiety, and 1 assessed death by suicide. Three studies included trans-feminine people only; 7 included trans-masculine people only, and 10 included both. Three studies focused on adolescents. Hormone therapy was associated with increased QOL, decreased depression, and decreased anxiety. Associations were similar across gender identity and age. Certainty in this conclusion is limited by high risk of bias in study designs, small sample sizes, and confounding with other interventions. We could not draw any conclusions about death by suicide. Future studies should investigate the psychological benefits of hormone therapy among larger and more diverse groups of transgender people using study designs that more effectively isolate the effects of hormone treatment. We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched PubMed, Embase, and PsycINFO through June 10, 2020 for studies evaluating quality of life (QOL), depression, anxiety, and death by suicide in the context of gender-affirming hormone therapy among transgender people of any age. We excluded case studies and studies reporting on less than 3 months of follow-up. We included 20 studies reported in 22 publications. Fifteen were trials or prospective cohorts, one was a retrospective cohort, and 4 were cross-sectional. Seven assessed QOL, 12 assessed depression, 8 assessed anxiety, and 1 assessed death by suicide. Three studies included trans-feminine people only; 7 included trans-masculine people only, and 10 included both. Three studies focused on adolescents. Hormone therapy was associated with increased QOL, decreased depression, and decreased anxiety. Associations were similar across gender identity and age. Certainty in this conclusion is limited by high risk of bias in study designs, small sample sizes, and confounding with other interventions. We could not draw any conclusions about death by suicide. Future studies should investigate the psychological benefits of hormone therapy among larger and more diverse groups of transgender people using study designs that more effectively isolate the effects of hormone treatment. We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched PubMed, Embase, and PsycINFO through June 10, 2020 for studies evaluating quality of life (QOL), depression, anxiety, and death by suicide in the context of gender-affirming hormone therapy among transgender people of any age. We excluded case studies and studies reporting on less than 3 months of follow-up. We included 20 studies reported in 22 publications. Fifteen were trials or prospective cohorts, one was a retrospective cohort, and 4 were cross-sectional. Seven assessed QOL, 12 assessed depression, 8 assessed anxiety, and 1 assessed death by suicide. Three studies included trans-feminine people only; 7 included trans-masculine people only, and 10 included both. Three studies focused on adolescents. Hormone therapy was associated with increased QOL, decreased depression, and decreased anxiety. Associations were similar across gender identity and age. Certainty in this conclusion is limited by high risk of bias in study designs, small sample sizes, and confounding with other interventions. We could not draw any conclusions about death by suicide. Future studies should investigate the psychological benefits of hormone therapy among larger and more diverse groups of transgender people using study designs that more effectively isolate the effects of hormone treatment. Key Words: Transgender, hormone therapy, sex hormones, mental health, systematic review |
Audience | Academic |
Author | McArthur, Kristen Robinson, Karen A Baker, Kellan E Sharma, Ritu Dukhanin, Vadim Wilson, Lisa M |
AuthorAffiliation | 3 Johns Hopkins Evidence-Based Practice Center , Baltimore, MD, USA 1 Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD, USA 2 Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD, USA |
AuthorAffiliation_xml | – name: 3 Johns Hopkins Evidence-Based Practice Center , Baltimore, MD, USA – name: 1 Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD, USA – name: 2 Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD, USA |
Author_xml | – sequence: 1 givenname: Kellan E orcidid: 0000-0002-9716-7936 surname: Baker fullname: Baker, Kellan E email: kbaker39@jhu.edu – sequence: 2 givenname: Lisa M surname: Wilson fullname: Wilson, Lisa M – sequence: 3 givenname: Ritu surname: Sharma fullname: Sharma, Ritu – sequence: 4 givenname: Vadim surname: Dukhanin fullname: Dukhanin, Vadim – sequence: 5 givenname: Kristen surname: McArthur fullname: McArthur, Kristen – sequence: 6 givenname: Karen A surname: Robinson fullname: Robinson, Karen A |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33644622$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1rGzEQxUVJaT6vPRZBLy3Eib525c2hYEITF1yatu5ZaKVZW0G72kq7Dv7vq2A3pBAoOkiMfvOYee8YHXShA4TeUnJBGSWX99DZFC7rja4Jpa_QEROSTWgl2cGz9yE6S-meEEIrLioh3qBDzkshSsaOkJ6H2GZVvFxD1P32HH-FbtAez0H7YX2OdWfx91F7N2xxaPDCNYBnuWOFl1F3aZVHgIjvIPQervAM_9ymAVo9OIN_wMbBwyl63Wif4Gx_n6BfN5-X1_PJ4tvtl-vZYmIEo8OkqYQ1lMlSClLWU1EYywivJfDS2KawUyILZhgQUjBODaOFrrXNLrCCWw6Sn6BPO91-rFuwJq8RtVd9dK2OWxW0U__-dG6tVmGj5LQSTFRZ4MNeIIbfI6RBtS4Z8F53EMakMiOmkgvBMvp-h660B-W6JmRF84irmZRF9lYSkamLF6h8LLTOZNMbl-svNZgYUorQPE1PiXpMXO0SV_vEc8O75zs_4X_zzcDHHRDG_n9ifwA1x7d2 |
CitedBy_id | crossref_primary_10_1136_bmjopen_2022_067575 crossref_primary_10_1002_cpt_2234 crossref_primary_10_7326_M24_0636 crossref_primary_10_1016_j_eprac_2023_03_003 crossref_primary_10_7759_cureus_36484 crossref_primary_10_1056_NEJMp2106314 crossref_primary_10_1093_ofid_ofab404 crossref_primary_10_1007_s10508_024_02809_5 crossref_primary_10_47671_TVG_80_24_030 crossref_primary_10_1016_j_psyneuen_2023_106319 crossref_primary_10_1016_j_jsxm_2021_09_008 crossref_primary_10_1016_j_socscimed_2024_116681 crossref_primary_10_1080_0092623X_2022_2136117 crossref_primary_10_1016_j_jadohealth_2023_01_031 crossref_primary_10_1007_s10689_023_00341_4 crossref_primary_10_1016_j_jsxm_2022_03_603 crossref_primary_10_1016_j_cpr_2022_102229 crossref_primary_10_2174_1573401319666230530095256 crossref_primary_10_1136_archdischild_2023_326669 crossref_primary_10_1057_s41599_022_01291_5 crossref_primary_10_1590_0034_7167_2022_0183pt crossref_primary_10_1055_a_2188_8898 crossref_primary_10_1080_26410397_2022_2045066 crossref_primary_10_1152_ajpheart_00346_2023 crossref_primary_10_1111_hiv_13677 crossref_primary_10_1080_13697137_2023_2176217 crossref_primary_10_1089_trgh_2021_0160 crossref_primary_10_1136_archdischild_2023_326670 crossref_primary_10_1016_j_acra_2023_10_037 crossref_primary_10_1186_s12991_023_00460_3 crossref_primary_10_1016_j_drugpo_2021_103366 crossref_primary_10_1093_pch_pxad087 crossref_primary_10_1093_jalm_jfae013 crossref_primary_10_1080_17437199_2024_2314506 crossref_primary_10_1089_trgh_2022_0165 crossref_primary_10_1080_26895269_2024_2323514 crossref_primary_10_1186_s13643_024_02566_5 crossref_primary_10_1097_HRP_0000000000000392 crossref_primary_10_1136_archdischild_2023_326681 crossref_primary_10_15585_mmwr_su7301a6 crossref_primary_10_1177_20420188221083512 crossref_primary_10_1200_EDBK_397264 crossref_primary_10_1016_j_japh_2023_08_016 crossref_primary_10_15585_mmwr_su7301a4 crossref_primary_10_1038_s41443_021_00490_z crossref_primary_10_1007_s11606_023_08531_7 crossref_primary_10_1177_15579883211062681 crossref_primary_10_1007_s00127_022_02359_y crossref_primary_10_1192_bjo_2022_51 crossref_primary_10_1093_ajhp_zxad320 crossref_primary_10_1007_s11136_024_03664_6 crossref_primary_10_1007_s00787_024_02440_8 crossref_primary_10_1007_s10815_023_03013_5 crossref_primary_10_1245_s10434_024_15319_4 crossref_primary_10_3389_fendo_2024_1086158 crossref_primary_10_3390_biomedicines11030670 crossref_primary_10_1210_clinem_dgae226 crossref_primary_10_1590_0034_7167_2022_0183 crossref_primary_10_7326_M23_0704 crossref_primary_10_1186_s12879_021_06782_5 crossref_primary_10_1016_j_psychres_2021_114272 crossref_primary_10_1038_s41591_022_02082_w crossref_primary_10_1001_jamanetworkopen_2024_11322 crossref_primary_10_1055_a_1891_8158 crossref_primary_10_37226_rcp_v8i1_8069 crossref_primary_10_1210_jendso_bvab105 crossref_primary_10_1016_j_cpha_2024_02_006 crossref_primary_10_1080_26895269_2024_2289318 crossref_primary_10_1136_archdischild_2023_326500 crossref_primary_10_1016_j_cpha_2024_02_005 crossref_primary_10_1016_j_medj_2021_04_025 crossref_primary_10_1001_jamanetworkopen_2023_31919 crossref_primary_10_1016_j_tips_2022_03_006 crossref_primary_10_3389_fgwh_2023_1126946 crossref_primary_10_1080_00207411_2022_2068319 crossref_primary_10_1146_annurev_publhealth_052620_100313 crossref_primary_10_3390_healthcare11050668 crossref_primary_10_1007_s11940_022_00728_1 crossref_primary_10_1177_26318318231189836 crossref_primary_10_1080_26895269_2023_2290132 crossref_primary_10_1089_trgh_2023_0177 crossref_primary_10_1146_annurev_med_020222_121106 crossref_primary_10_1080_26895269_2024_2333525 crossref_primary_10_3389_fnhum_2023_1303871 crossref_primary_10_1016_j_esxm_2022_100533 crossref_primary_10_1080_0092623X_2023_2300828 crossref_primary_10_1080_10345329_2023_2231112 crossref_primary_10_1136_bmj_p382 crossref_primary_10_1136_bmj_p1877 crossref_primary_10_1080_13691058_2024_2358099 crossref_primary_10_1016_j_asmr_2023_04_019 crossref_primary_10_1080_00918369_2023_2186759 crossref_primary_10_3390_ijerph19020869 crossref_primary_10_1038_s41562_023_01605_w crossref_primary_10_1891_LGBTQ_2020_0019 crossref_primary_10_1111_jpm_12933 crossref_primary_10_1136_archdischild_2023_326760 crossref_primary_10_1080_0092623X_2022_2070565 crossref_primary_10_1080_26895269_2022_2100644 crossref_primary_10_3390_healthcare11030379 crossref_primary_10_1089_trgh_2021_0139 crossref_primary_10_1093_abm_kaad035 crossref_primary_10_1051_medsci_2022151 crossref_primary_10_1080_15313204_2024_2338384 crossref_primary_10_1016_j_lana_2023_100568 crossref_primary_10_1089_lgbt_2023_0418 crossref_primary_10_21886_2219_8075_2022_13_3_83_92 |
Cites_doi | 10.1016/S0140-6736(16)00682-6 10.1136/bmj.i4919 10.1037/a0037599 10.1016/j.jclinepi.2014.11.023 10.1016/j.euroneuro.2014.11.019 10.1186/s13633-020-00078-2 10.1371/journal.pone.0221583 10.1080/15532739.2011.700873 10.1016/j.psyneuen.2013.09.029 10.1016/j.psychres.2019.03.053 10.1080/15532739.2014.899174 10.1046/j.1365-2265.1997.2601068.x 10.1530/EJE-10-1038 10.1002/(SICI)1099-1557(199705)6:3<169::AID-PDS263>3.0.CO;2-3 10.1016/0026-0495(89)90233-3 10.1136/bmj.b2535 10.1111/jsm.12363 10.1016/j.jsxm.2016.02.001 10.1210/jc.2016-1276 10.1210/jc.2017-01658 10.11124/JBISRIR-2017-003869 10.1016/S2215-0366(16)30165-1 10.1080/0092623X.2012.736920 10.1186/s12888-017-1423-y 10.1097/NMD.0000000000000046 10.1080/00223890802108022 10.1007/s10508-018-1189-4 10.1016/j.jsxm.2018.03.079 10.1080/15532739.2015.1039176 10.1016/S2213-8587(18)30305-X 10.1136/bmj.l4898 10.1111/j.1365-2265.2009.03625.x 10.1542/peds.2013-2958 10.1089/trgh.2015.0008 10.1097/00005053-198011000-00009 10.5603/EP.2015.0008 10.1016/j.jsxm.2017.11.004 10.1111/acps.13164 10.1016/j.psyneuen.2011.08.010 10.1111/jsm.12698 10.1111/cen.13050 10.1080/15532739.2017.1314796 10.1176/appi.books.9780890425596 10.1016/j.anpedi.2020.01.019 10.1016/j.ecl.2019.01.001 10.1530/EJE-07-0511 10.1080/19317611.2013.833152 10.1080/19359705.2011.581195 10.1111/j.1743-6109.2011.02348.x 10.1007/s11136-006-0002-3 10.1111/j.1743-6109.2010.01943.x 10.1111/j.1743-6109.2011.02564.x 10.1177/0022167817745217 10.2147/NDT.S95310 10.1080/13691058.2014.950982 10.1111/cen.13821 10.1007/s11154-018-9459-y |
ContentType | Journal Article |
Copyright | The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. 2021 The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. COPYRIGHT 2021 Oxford University Press |
Copyright_xml | – notice: The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. 2021 – notice: The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. – notice: COPYRIGHT 2021 Oxford University Press |
DBID | TOX NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1210/jendso/bvab011 |
DatabaseName | Oxford Open (Open Access) PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: TOX name: Oxford University Press Open Access url: https://academic.oup.com/journals/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2472-1972 |
EndPage | bvab011 |
ExternalDocumentID | A775446704 10_1210_jendso_bvab011 33644622 10.1210/jendso/bvab011 |
Genre | Journal Article Review |
GrantInformation_xml | – fundername: ; |
GroupedDBID | 0R~ 53G AAFWJ AAPPN AAPXW AAVAP ABPTD ABXVV ACGFS ADBBV AENZO AFPKN AFULF ALMA_UNASSIGNED_HOLDINGS AOIJS BAYMD BCNDV BTTYL EBS EJD EMOBN GROUPED_DOAJ H13 HYE IAO KQ8 KSI ML0 M~E O9- OK1 ROX RPM TJX TOX ABEJV ITC NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c421t-f94dc12767406b845cd203b7e36cdf5d80752c2e005231c215abad210253d3e73 |
IEDL.DBID | RPM |
ISSN | 2472-1972 |
IngestDate | Tue Sep 17 21:07:22 EDT 2024 Fri Dec 06 00:16:14 EST 2024 Tue Nov 19 21:46:18 EST 2024 Tue Nov 12 23:50:37 EST 2024 Fri Dec 06 01:15:33 EST 2024 Sat Nov 02 12:25:43 EDT 2024 Wed Aug 28 03:17:16 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Transgender hormone therapy sex hormones systematic review mental health |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. http://creativecommons.org/licenses/by-nc-nd/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c421t-f94dc12767406b845cd203b7e36cdf5d80752c2e005231c215abad210253d3e73 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ORCID | 0000-0002-9716-7936 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894249/ |
PMID | 33644622 |
PQID | 2494873442 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7894249 proquest_miscellaneous_2494873442 gale_infotracmisc_A775446704 gale_infotracacademiconefile_A775446704 crossref_primary_10_1210_jendso_bvab011 pubmed_primary_33644622 oup_primary_10_1210_jendso_bvab011 |
PublicationCentury | 2000 |
PublicationDate | 2021-04-01 |
PublicationDateYYYYMMDD | 2021-04-01 |
PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | US |
PublicationPlace_xml | – name: US – name: United States |
PublicationTitle | Journal of the Endocrine Society |
PublicationTitleAlternate | J Endocr Soc |
PublicationYear | 2021 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | van Kesteren (2021022011481483000_CIT0064) 1997; 47 Sterne (2021022011481483000_CIT0024) 2019; 366 Wierckx (2021022011481483000_CIT0048) 2011; 8 Heylens (2021022011481483000_CIT0053) 2014; 11 Warmuz-Stangierska (2021022011481483000_CIT0058) 2015; 66 Pelusi (2021022011481483000_CIT0027) 2014; 11 Fuss (2021022011481483000_CIT0037) 2015; 25 Defreyne (2021022011481483000_CIT0033) 2018; 15 Davis (2021022011481483000_CIT0060) 2014; 26 Sharma (2021022011481483000_CIT0018) Metzger (2021022011481483000_CIT0040) 2019; 276 Wiepjes (2021022011481483000_CIT0065) 2020; 141 Robles (2021022011481483000_CIT0010) 2016; 3 Newfield (2021022011481483000_CIT0062) 2006; 15 Rohatgi (2021022011481483000_CIT0023) 2020 Thompson (2021022011481483000_CIT0051) 2015; 16 Oda (2021022011481483000_CIT0056) 2017; 17 Collin (2021022011481483000_CIT0001) 2016; 13 de Vries (2021022011481483000_CIT0035) 2014; 134 Colton Meier (2021022011481483000_CIT0059) 2011; 15 Elaut (2021022011481483000_CIT0057) 2008; 158 Murad (2021022011481483000_CIT0012) 2010; 72 Asscheman (2021022011481483000_CIT0044) 2011; 164 James (2021022011481483000_CIT0005) 2016 Baker (2021022011481483000_CIT0020); V1 Colizzi (2021022011481483000_CIT0031) 2014; 39 Schulz (2021022011481483000_CIT0008) 2018; 58 American Psychiatric Association (2021022011481483000_CIT0009) 2013 Ware (2021022011481483000_CIT0022) 1995; 33 Nobili (2021022011481483000_CIT0015) 2018; 19 Berkman (2021022011481483000_CIT0026) 2015; 68 Wylie (2021022011481483000_CIT0007) 2016; 388 Gava (2021022011481483000_CIT0029) 2018; 89 Motta (2021022011481483000_CIT0041) 2018; 15 Turan (2021022011481483000_CIT0042) 2018; 47 Costantino (2021022011481483000_CIT0032) 2013; 39 Mahfouda (2021022011481483000_CIT0017) 2019; 7 Keo-Meier (2021022011481483000_CIT0061) 2015; 83 Gómez-Gil (2021022011481483000_CIT0055) 2008; 90 Costa (2021022011481483000_CIT0014) 2016; 12 Sterne (2021022011481483000_CIT0025) 2016; 355 López de Lara (2021022011481483000_CIT0038) 2020; 93 Goodman (2021022011481483000_CIT0002) 2019; 48 Arístegui (2021022011481483000_CIT0011) 2017; 18 Gómez-Gil (2021022011481483000_CIT0045) 2012; 37 Leavitt (2021022011481483000_CIT0047) 1980; 168 Deutsch (2021022011481483000_CIT0006) 2016 Webb (2021022011481483000_CIT0052) 2016 Moher (2021022011481483000_CIT0019) 2009; 339 Achille (2021022011481483000_CIT0030) 2020; 2020 Hembree (2021022011481483000_CIT0004) 2017; 102 Fisher (2021022011481483000_CIT0036) 2016; 101 (2021022011481483000_CIT0021) 2020 Gooren (2021022011481483000_CIT0063) 2015; 17 Asscheman (2021022011481483000_CIT0043) 1989; 38 Gorin-Lazard (2021022011481483000_CIT0054) 2013; 201 White Hughto (2021022011481483000_CIT0013) 2016; 1 de Vries (2021022011481483000_CIT0034) 2011; 8 Coleman (2021022011481483000_CIT0003) 2012; 13 Gava (2021022011481483000_CIT0028) 2016; 85 Manieri (2021022011481483000_CIT0039) 2014; 15 Rowniak (2021022011481483000_CIT0016) 2019; 17 Gorin-Lazard (2021022011481483000_CIT0046) 2012; 9 Reisner (2021022011481483000_CIT0050) 2019; 14 Heinemann (2021022011481483000_CIT0049) 1997; 6 |
References_xml | – volume: 388 start-page: 401 issue: 10042 year: 2016 ident: 2021022011481483000_CIT0007 article-title: Serving transgender people: clinical care considerations and service delivery models in transgender health publication-title: Lancet. doi: 10.1016/S0140-6736(16)00682-6 contributor: fullname: Wylie – volume: 355 start-page: i4919 year: 2016 ident: 2021022011481483000_CIT0025 article-title: ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions publication-title: BMJ. doi: 10.1136/bmj.i4919 contributor: fullname: Sterne – volume: 83 start-page: 143 issue: 1 year: 2015 ident: 2021022011481483000_CIT0061 article-title: Testosterone treatment and MMPI-2 improvement in transgender men: a prospective controlled study publication-title: J Consult Clin Psychol. doi: 10.1037/a0037599 contributor: fullname: Keo-Meier – volume: 68 start-page: 1312 issue: 11 year: 2015 ident: 2021022011481483000_CIT0026 article-title: Grading the strength of a body of evidence when assessing health care interventions: an EPC update publication-title: J Clin Epidemiol. doi: 10.1016/j.jclinepi.2014.11.023 contributor: fullname: Berkman – volume: 25 start-page: 95 issue: 1 year: 2015 ident: 2021022011481483000_CIT0037 article-title: Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF) publication-title: Eur Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2014.11.019 contributor: fullname: Fuss – volume: 2020 start-page: 8 year: 2020 ident: 2021022011481483000_CIT0030 article-title: Longitudinal impact of gender-affirming endocrine intervention on the mental health and well-being of transgender youths: preliminary results publication-title: Int J Pediatr Endocrinol. doi: 10.1186/s13633-020-00078-2 contributor: fullname: Achille – volume: 14 start-page: e0221583 issue: 8 year: 2019 ident: 2021022011481483000_CIT0050 article-title: Comparing the health of non-binary and binary transgender adults in a statewide non-probability sample publication-title: Plos One. doi: 10.1371/journal.pone.0221583 contributor: fullname: Reisner – volume: 13 start-page: 165 issue: 4 year: 2012 ident: 2021022011481483000_CIT0003 article-title: Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7 publication-title: Int J Transgenderism. doi: 10.1080/15532739.2011.700873 contributor: fullname: Coleman – volume: 39 start-page: 65 year: 2014 ident: 2021022011481483000_CIT0031 article-title: Transsexual patients’ psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study publication-title: Psychoneuroendocrinology. doi: 10.1016/j.psyneuen.2013.09.029 contributor: fullname: Colizzi – volume: 276 start-page: 31 year: 2019 ident: 2021022011481483000_CIT0040 article-title: The effect of testosterone therapy on personality traits of trans men: a controlled prospective study in Germany and Switzerland publication-title: Psychiatry Res. doi: 10.1016/j.psychres.2019.03.053 contributor: fullname: Metzger – volume: 15 start-page: 53 issue: 2 year: 2014 ident: 2021022011481483000_CIT0039 article-title: Medical treatment of subjects with gender identity disorder: the experience in an Italian Public Health Center publication-title: Int J Transgenderism. doi: 10.1080/15532739.2014.899174 contributor: fullname: Manieri – volume: 47 start-page: 337 issue: 3 year: 1997 ident: 2021022011481483000_CIT0064 article-title: Mortality and morbidity in transsexual subjects treated with cross-sex hormones publication-title: Clin Endocrinol (Oxf). doi: 10.1046/j.1365-2265.1997.2601068.x contributor: fullname: van Kesteren – volume: 164 start-page: 635 issue: 4 year: 2011 ident: 2021022011481483000_CIT0044 article-title: A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones publication-title: Eur J Endocrinol. doi: 10.1530/EJE-10-1038 contributor: fullname: Asscheman – volume: 6 start-page: 169 issue: 3 year: 1997 ident: 2021022011481483000_CIT0049 article-title: Safety of cyproterone acetate: report of active surveillance publication-title: Pharmacoepidemiol Drug Saf. doi: 10.1002/(SICI)1099-1557(199705)6:3<169::AID-PDS263>3.0.CO;2-3 contributor: fullname: Heinemann – volume: V1 ident: 2021022011481483000_CIT0020 article-title: Data associated with the publication: Hormone therapy, mental health, and quality of life among transgender people: a systematic review publication-title: Johns Hopkins Univ Data Arch. contributor: fullname: Baker – volume: 38 start-page: 869 issue: 9 year: 1989 ident: 2021022011481483000_CIT0043 article-title: Mortality and morbidity in transsexual patients with cross-gender hormone treatment publication-title: Metabolism. doi: 10.1016/0026-0495(89)90233-3 contributor: fullname: Asscheman – volume: 339 start-page: b2535 year: 2009 ident: 2021022011481483000_CIT0019 article-title: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement publication-title: BMJ. doi: 10.1136/bmj.b2535 contributor: fullname: Moher – volume: 11 start-page: 119 issue: 1 year: 2014 ident: 2021022011481483000_CIT0053 article-title: Effects of different steps in gender reassignment therapy on psychopathology: a prospective study of persons with a gender identity disorder publication-title: J Sex Med. doi: 10.1111/jsm.12363 contributor: fullname: Heylens – ident: 2021022011481483000_CIT0018 contributor: fullname: Sharma – volume: 13 start-page: 613 issue: 4 year: 2016 ident: 2021022011481483000_CIT0001 article-title: Prevalence of transgender depends on the “case” definition: a systematic review publication-title: J Sex Med. doi: 10.1016/j.jsxm.2016.02.001 contributor: fullname: Collin – volume: 101 start-page: 4260 issue: 11 year: 2016 ident: 2021022011481483000_CIT0036 article-title: Cross-sex hormone treatment and psychobiological changes in transsexual persons: two-year follow-up data publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2016-1276 contributor: fullname: Fisher – volume: 102 start-page: 3869 issue: 11 year: 2017 ident: 2021022011481483000_CIT0004 article-title: Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2017-01658 contributor: fullname: Hembree – volume: 17 start-page: 1826 issue: 9 year: 2019 ident: 2021022011481483000_CIT0016 article-title: Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review publication-title: JBI Database System Rev Implement Rep. doi: 10.11124/JBISRIR-2017-003869 contributor: fullname: Rowniak – year: 2016 ident: 2021022011481483000_CIT0006 contributor: fullname: Deutsch – volume: 3 start-page: 850 issue: 9 year: 2016 ident: 2021022011481483000_CIT0010 article-title: Removing transgender identity from the classification of mental disorders: a Mexican field study for ICD-11 publication-title: Lancet Psychiatry. doi: 10.1016/S2215-0366(16)30165-1 contributor: fullname: Robles – volume: 39 start-page: 321 issue: 4 year: 2013 ident: 2021022011481483000_CIT0032 article-title: A prospective study on sexual function and mood in female-to-male transsexuals during testosterone administration and after sex reassignment surgery publication-title: J Sex Marital Ther. doi: 10.1080/0092623X.2012.736920 contributor: fullname: Costantino – volume: 17 start-page: 256 issue: 1 year: 2017 ident: 2021022011481483000_CIT0056 article-title: Efficacy of hormonal and mental treatments with MMPI in FtM individuals: cross-sectional and longitudinal studies publication-title: BMC Psychiatry. doi: 10.1186/s12888-017-1423-y contributor: fullname: Oda – volume: 201 start-page: 996 issue: 11 year: 2013 ident: 2021022011481483000_CIT0054 article-title: Hormonal therapy is associated with better self-esteem, mood, and quality of life in transsexuals publication-title: J Nerv Ment Dis. doi: 10.1097/NMD.0000000000000046 contributor: fullname: Gorin-Lazard – volume: 90 start-page: 368 issue: 4 year: 2008 ident: 2021022011481483000_CIT0055 article-title: MMPI-2 characteristics of transsexuals requesting sex reassignment: comparison of patients in prehormonal and presurgical phases publication-title: J Pers Assess. doi: 10.1080/00223890802108022 contributor: fullname: Gómez-Gil – volume: 47 start-page: 2349 issue: 8 year: 2018 ident: 2021022011481483000_CIT0042 article-title: Alterations in body uneasiness, eating attitudes, and psychopathology before and after cross-sex hormonal treatment in patients with female-to-male gender dysphoria publication-title: Arch Sex Behav. doi: 10.1007/s10508-018-1189-4 contributor: fullname: Turan – volume: 15 start-page: 768 issue: 5 year: 2018 ident: 2021022011481483000_CIT0033 article-title: Prospective evaluation of self-reported aggression in transgender persons publication-title: J Sex Med. doi: 10.1016/j.jsxm.2018.03.079 contributor: fullname: Defreyne – volume: 16 start-page: 36 issue: 1 year: 2015 ident: 2021022011481483000_CIT0051 article-title: Quality-of-life measurement: assessing the WHOQOL-BREF scale in a sample of high-HIV-risk transgender women in San Francisco, California publication-title: Int J Transgend. doi: 10.1080/15532739.2015.1039176 contributor: fullname: Thompson – volume-title: The Report of the 2015 U.S. Transgender Survey year: 2016 ident: 2021022011481483000_CIT0005 contributor: fullname: James – volume: 7 start-page: 484 issue: 6 year: 2019 ident: 2021022011481483000_CIT0017 article-title: Gender-affirming hormones and surgery in transgender children and adolescents publication-title: Lancet Diabetes Endocrinol. doi: 10.1016/S2213-8587(18)30305-X contributor: fullname: Mahfouda – volume: 366 start-page: l4898 year: 2019 ident: 2021022011481483000_CIT0024 article-title: RoB 2: a revised tool for assessing risk of bias in randomised trials publication-title: BMJ. doi: 10.1136/bmj.l4898 contributor: fullname: Sterne – volume: 72 start-page: 214 issue: 2 year: 2010 ident: 2021022011481483000_CIT0012 article-title: Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes publication-title: Clin Endocrinol (Oxf). doi: 10.1111/j.1365-2265.2009.03625.x contributor: fullname: Murad – volume: 134 start-page: 696 issue: 4 year: 2014 ident: 2021022011481483000_CIT0035 article-title: Young adult psychological outcome after puberty suppression and gender reassignment publication-title: Pediatrics. doi: 10.1542/peds.2013-2958 contributor: fullname: de Vries – volume: 1 start-page: 21 issue: 1 year: 2016 ident: 2021022011481483000_CIT0013 article-title: A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals publication-title: Transgend Health. doi: 10.1089/trgh.2015.0008 contributor: fullname: White Hughto – volume: 168 start-page: 693 issue: 11 year: 1980 ident: 2021022011481483000_CIT0047 article-title: Presurgical adjustment in male transsexuals with and without hormonal treatment publication-title: J Nerv Ment Dis. doi: 10.1097/00005053-198011000-00009 contributor: fullname: Leavitt – volume: 66 start-page: 47 issue: 1 year: 2015 ident: 2021022011481483000_CIT0058 article-title: Emotional functions in transsexuals after the first step in physical transformation publication-title: Endokrynol Pol. doi: 10.5603/EP.2015.0008 contributor: fullname: Warmuz-Stangierska – volume: 15 start-page: 94 issue: 1 year: 2018 ident: 2021022011481483000_CIT0041 article-title: Does testosterone treatment increase anger expression in a population of transgender men? publication-title: J Sex Med. doi: 10.1016/j.jsxm.2017.11.004 contributor: fullname: Motta – volume: 141 start-page: 486 issue: 6 year: 2020 ident: 2021022011481483000_CIT0065 article-title: Trends in suicide death risk in transgender people: results from the Amsterdam Cohort of Gender Dysphoria study (1972-2017) publication-title: Acta Psychiatr Scand. doi: 10.1111/acps.13164 contributor: fullname: Wiepjes – year: 2020 ident: 2021022011481483000_CIT0023 contributor: fullname: Rohatgi – year: 2016 ident: 2021022011481483000_CIT0052 contributor: fullname: Webb – volume: 37 start-page: 662 issue: 5 year: 2012 ident: 2021022011481483000_CIT0045 article-title: Hormone-treated transsexuals report less social distress, anxiety and depression publication-title: Psychoneuroendocrinology. doi: 10.1016/j.psyneuen.2011.08.010 contributor: fullname: Gómez-Gil – volume: 11 start-page: 3002 issue: 12 year: 2014 ident: 2021022011481483000_CIT0027 article-title: Effects of three different testosterone formulations in female-to-male transsexual persons publication-title: J Sex Med. doi: 10.1111/jsm.12698 contributor: fullname: Pelusi – volume: 85 start-page: 239 issue: 2 year: 2016 ident: 2021022011481483000_CIT0028 article-title: Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness publication-title: Clin Endocrinol (Oxf). doi: 10.1111/cen.13050 contributor: fullname: Gava – volume: 18 start-page: 446 issue: 4 year: 2017 ident: 2021022011481483000_CIT0011 article-title: Impact of the Gender Identity Law in Argentinean transgender women publication-title: Int J Transgenderism. doi: 10.1080/15532739.2017.1314796 contributor: fullname: Arístegui – volume-title: Diagnostic and Statistical Manual of Mental Disorders year: 2013 ident: 2021022011481483000_CIT0009 doi: 10.1176/appi.books.9780890425596 contributor: fullname: American Psychiatric Association – volume: 93 start-page: 41 issue: 1 year: 2020 ident: 2021022011481483000_CIT0038 article-title: Evaluación psicosocial en adolescentes transgénero publication-title: An Pediatría. doi: 10.1016/j.anpedi.2020.01.019 contributor: fullname: López de Lara – volume: 48 start-page: 303 issue: 2 year: 2019 ident: 2021022011481483000_CIT0002 article-title: Size and distribution of transgender and gender nonconforming populations: a narrative review publication-title: Endocrinol Metab Clin North Am. doi: 10.1016/j.ecl.2019.01.001 contributor: fullname: Goodman – volume: 158 start-page: 393 issue: 3 year: 2008 ident: 2021022011481483000_CIT0057 article-title: Hypoactive sexual desire in transsexual women: prevalence and association with testosterone levels publication-title: Eur J Endocrinol. doi: 10.1530/EJE-07-0511 contributor: fullname: Elaut – volume: 26 start-page: 113 issue: 2 year: 2014 ident: 2021022011481483000_CIT0060 article-title: Effects of testosterone treatment and chest reconstruction surgery on mental health and sexuality in female-to-male transgender people publication-title: Int J Sex Health. doi: 10.1080/19317611.2013.833152 contributor: fullname: Davis – volume: 15 start-page: 281 issue: 3 year: 2011 ident: 2021022011481483000_CIT0059 article-title: The effects of hormonal gender affirmation treatment on mental health in female-to-male transsexuals publication-title: J Gay Lesbian Ment Health. doi: 10.1080/19359705.2011.581195 contributor: fullname: Colton Meier – volume: 8 start-page: 3379 issue: 12 year: 2011 ident: 2021022011481483000_CIT0048 article-title: Quality of life and sexual health after sex reassignment surgery in transsexual men publication-title: J Sex Med. doi: 10.1111/j.1743-6109.2011.02348.x contributor: fullname: Wierckx – volume: 15 start-page: 1447 issue: 9 year: 2006 ident: 2021022011481483000_CIT0062 article-title: Female-to-male transgender quality of life publication-title: Qual Life Res. doi: 10.1007/s11136-006-0002-3 contributor: fullname: Newfield – volume: 8 start-page: 2276 issue: 8 year: 2011 ident: 2021022011481483000_CIT0034 article-title: Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study publication-title: J Sex Med. doi: 10.1111/j.1743-6109.2010.01943.x contributor: fullname: de Vries – volume: 9 start-page: 531 issue: 2 year: 2012 ident: 2021022011481483000_CIT0046 article-title: Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study publication-title: J Sex Med. doi: 10.1111/j.1743-6109.2011.02564.x contributor: fullname: Gorin-Lazard – volume: 58 start-page: 72 issue: 1 year: 2018 ident: 2021022011481483000_CIT0008 article-title: The informed consent model of transgender care: an alternative to the diagnosis of gender dysphoria publication-title: J Humanist Psychol. doi: 10.1177/0022167817745217 contributor: fullname: Schulz – volume: 12 start-page: 1953 year: 2016 ident: 2021022011481483000_CIT0014 article-title: The effect of cross-sex hormonal treatment on gender dysphoria individuals’ mental health: a systematic review publication-title: Neuropsychiatr Dis Treat. doi: 10.2147/NDT.S95310 contributor: fullname: Costa – volume: 33 start-page: AS264 issue: 4 Suppl year: 1995 ident: 2021022011481483000_CIT0022 article-title: Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study publication-title: Med Care. contributor: fullname: Ware – volume: 17 start-page: 92 issue: 1 year: 2015 ident: 2021022011481483000_CIT0063 article-title: Cross-sex hormone use, functional health and mental well-being among transgender men (Toms) and Transgender Women (Kathoeys) in Thailand publication-title: Cult Health Sex. doi: 10.1080/13691058.2014.950982 contributor: fullname: Gooren – volume-title: Evidence Partners year: 2020 ident: 2021022011481483000_CIT0021 – volume: 89 start-page: 878 issue: 6 year: 2018 ident: 2021022011481483000_CIT0029 article-title: Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration publication-title: Clin Endocrinol (Oxf). doi: 10.1111/cen.13821 contributor: fullname: Gava – volume: 19 start-page: 199 issue: 3 year: 2018 ident: 2021022011481483000_CIT0015 article-title: Quality of life of treatment-seeking transgender adults: a systematic review and meta-analysis publication-title: Rev Endocr Metab Disord. doi: 10.1007/s11154-018-9459-y contributor: fullname: Nobili |
SSID | ssj0001934944 |
Score | 2.5632524 |
SecondaryResourceType | review_article |
Snippet | Abstract
We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched... We sought to systematically review the effect of gender-affirming hormone therapy on psychological outcomes among transgender people. We searched PubMed,... |
SourceID | pubmedcentral proquest gale crossref pubmed oup |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | bvab011 |
SubjectTerms | Anxiety Case studies Conjugated estrogens Gender identity Mental health Meta-Analysis Psychological research Transgender people |
Title | Hormone Therapy, Mental Health, and Quality of Life Among Transgender People: A Systematic Review |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33644622 https://search.proquest.com/docview/2494873442 https://pubmed.ncbi.nlm.nih.gov/PMC7894249 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LTxsxEB4BB8Slailt0wIyVaVeWJLY3vUutwiBItS0SAQpt5VfC0Flg9qAxL_vjL0bZXup1Mte_JRnvDNjf_MZ4Eul0xzNtkiqTGOAoiVPCuV1krk817nTRWEoUXjyPRvfyMtZOtuAtM2FCaB9a-Yn9c-Hk3p-F7CVjw-23-LE-leTM5UXEsOG_iZsKp6vhejhYKUgxhXZEDRShso9gUsXffOsDWrzDmwLgV5AxnnHFjV_5E6a25q3-Tdocs0KXbyGV437yEZxmm9gw9e7sD1pLsjfgh6jD7qoPZtGtoBjFkl6WEw3Oma6dizyZrywRcW-zSvPRvTgEAtW6za8LMeuAq78lI3Y9YrpmcVrhD24uTifno2T5hWFxEo-XCZVIZ0dciLtGWQml6l1fCCM8iKzrkodsRFzy304IB5adAG00Y4iwVQ44ZV4B1s1TvwDMKPQecoMV0WOgRVGhqKwDrvzemBSI4c9-NquZ_kYyTJKCjKwszIKoWyEgDVpuUvaRbiaVjfJADgO8VGVo0DMl6mB7MF-pyZqv-0Uf0aB_XO0o1aeJbUnXFntF0-_S07sOEpIyXvwPsp31VerJT1QHcmvKhAzd7cEFTYwdDcK-vG_W36CHU7gmQAR2oet5a8nf4Dez9IchlODw6Dz-J3-mP0BVW8HkQ |
link.rule.ids | 230,315,728,781,785,865,886,27929,27930,53796,53798 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB6VIpVeEM8SKGAQEpduk9hee80tqqgCJFUlUqk3y6-FILqpIEXi3zO2d6MsFyTOtseWZ3Znxv7mM8Cb2pQVum1W1MJggmI4LZQMphC-qkzljVI2FgrPz8T0gn-8LC93oOxqYRJo39nlcfP96rhZfk3YyusrN-xwYsPz-YmsFMe0YXgLbpdMKrGVpKejFRU5V3hL0RhrVL5FeOlqaH8Zi_a8D3uMYRwgKO15o_af3Ct024o3_4ZNbvmh03twtw0gySQv9D7shOYB7M3bK_KHYKYYha6aQBaZL-CIZJoekguOjohpPMnMGb_JqiazZR3IJD45RJLf-pLeliPnCVn-jkzI5w3XM8kXCY_g4vT94mRatO8oFI7T8bqoFfduTCNtz0jYipfO0xGzMjDhfF36yEdMHQ3piHjsMAgw1viYC5bMsyDZY9htcOFPgFiJ4ZOwVKoKUyvMDZlyHsUFM7Kl5eMBvO32U19nugwd0wwUprMSdKsE7Bm3W8fvCHfTmbYcAOeJjFR6kqj5hBzxARz2eqL9u17za1TYP2d71elTx_ERWdaE1c1PTSM_jmSc0wEcZP1uZHVWMgDZ0_ymQ-Tm7regySaO7tZEn_73yJdwZ7qYz_Tsw9mnZ7BPI5QmAYYOYXf94yY8x1hobV8ky_8D-E4I2Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEB7SBEwuoY-0dZu2agj0ks3akna125tJa5yHg6EJ5Cb02sYhWZvWKeTfZyStjbeXQs_SSmJmtDMjffMJ4KBSWYFumyVVrjBBUZwmpXAqyW1RqMKqstS-UHh8kY-u-Ol1dr321FcA7Rs9Parv7o_q6U3AVs7vTbrEiaWT8bEoSo5pQzq3VfoMtjImymItUQ_HK6XnXeENTaOvU7n1ENNZqv8ojTa9DR3GMBbIKW15pOa_3Cp2W4s5_4ZOrvmi4XPYaYJIMoiLfQEbrn4JnXFzTf4K1Agj0VntyGXkDDgkkaqHxKKjQ6JqSyJ7xiOZVeR8Wjky8M8OkeC7fob35cgkoMu_kgH5seJ7JvEyYReuht8vj0dJ85ZCYjjtL5Kq5Nb0qafu6eW64JmxtMe0cCw3tsqs5ySmhrpwTNw3GAgorazPBzNmmRPsNWzWuPC3QLTAECrXFIWO6RXmh6w0Fodzqqczzftd-LKUp5xHygzpUw0cTEYlyEYJ2NOLW_q9hNI0qikJwHk8K5UcBHq-XPR4F_ZaPXEPmFbzPirsn7N9XupT-u89uqx2s4ffknqOHME4p114E_W7GmtpJV0QLc2vOnh-7nYLmm3g6W7M9N1_f_kJOpNvQ3l-cnH2HrapR9MEzNAebC5-PbgPGA4t9Mdg-E_B0Ans |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hormone+Therapy%2C+Mental+Health%2C+and+Quality+of+Life+Among+Transgender+People%3A+A+Systematic+Review&rft.jtitle=Journal+of+the+Endocrine+Society&rft.au=Baker%2C+Kellan+E&rft.au=Wilson%2C+Lisa+M&rft.au=Sharma%2C+Ritu&rft.au=Dukhanin%2C+Vadim&rft.date=2021-04-01&rft.pub=Oxford+University+Press&rft.issn=2472-1972&rft.eissn=2472-1972&rft.volume=5&rft.issue=4&rft_id=info:doi/10.1210%2Fjendso%2Fbvab011&rft.externalDocID=A775446704 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2472-1972&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2472-1972&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2472-1972&client=summon |